Merck KGaA raises outlook after forecast-beating Q2 profit Ruchika Sharma8 Aug 2021 9:15 AM ISTBerlin: Merck KGaA raised its outlook after posting forecast-beating second quarter profits on Thursday, boosted by demand for its lab gear and...
Merck gets USFDA nod for Pneumococcal 15-valent Conjugate Vaccine Ruchika Sharma18 July 2021 10:30 AM ISTKenilworth: Merck known as MSD outside the United States and Canada, has recently announced the U.S. Food and Drug Administration (USFDA) approved...
Unichem Labs diabetes drug Sitagliptin gets USFDA approval Ruchika Sharma11 July 2021 12:00 PM ISTSitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Patent Infringement: MSD sues firm in Delhi HC over diabetes drug Sitagliptin Medical Dialogues Team20 Jun 2021 11:30 AM ISTNew Delhi: In a major victory for Merck Sharp and Dohme (MSD) Corp, the Delhi High Court has restrained Solitaire Pharmacia Private from infringing...
Delhi HC Restrains Firm From Infringing on MSD Diabetes Drug Sitagliptin Medical Dialogues Team8 Jun 2021 8:36 PM ISTNew Delhi: In a major relief to Merck Sharp & Dohme Corp, the Delhi High Court has barred YMS Laboratories Private Limited from infringing on...
Sanofi-Merck six-in-one pediatric combination vaccine Vaxelis available in US Ruchika Sharma3 Jun 2021 11:00 AM ISTBridgewater: Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B...
Merck announces Rs 17.85 crores caring aid to India for COVID relief Ruchika Sharma3 Jun 2021 10:00 AM ISTMumbai: Merck has recently announced its support to India in combating the recent surge in Covid-19 cases.With the country grappling with...
Merck inks licensing pact with Cipla, Sun Pharma, 3 others for oral COVID drug Molnupiravir Medical Dialogues Team28 April 2021 11:51 AM ISTMumbai: In order to accelerate and expand global access to Molnupiravir for treating Covid-19, Merck (known as MSD Pharmaceuticals outside the United...
Himachal drugmaker agrees to destroy infringed stock of Merck Diabetes Drug Sitagliptin Medical Dialogues Team7 April 2021 6:42 PM ISTNew Delhi: In a relief to Merck, Hariom Pharmachem has agreed to destroy the stock of infringed products of Merck's popular diabetes drug Sitagliptin,...
Gilead Sciences, Merck collaborate to develop, commercialize Lenacapavir, Islatravir combo for HIV Ruchika Sharma17 March 2021 1:04 PM ISTFoster City & Kenilworth: Gilead Sciences, Inc. and Merck, known as MSD outside the United States and Canada, have recently announced that they...
Merck phase 1 trial for Islatravir subdermal implant to prevent HIV-1 Infection shows positive results Ruchika Sharma10 March 2021 11:30 AM ISTKenilworth: Merck, known as MSD outside the United States and Canada, has recently announced results from a Phase 1 study evaluating the safety,...
Merck to buy Pandion Therapeutics for USD 1.85 billion Ruchika Sharma28 Feb 2021 9:45 AM ISTKenilworth & Watertown: Merck, known as MSD outside the United States and Canada, and Pandion Therapeutics, Inc. have recently announced that the...
